Index of /rulepatterns/data-v3/data_per_entity/omab

[ICO]NameLast modifiedSizeDescription

[PARENTDIR]Parent Directory  -  
[   ]dbr-Abagovomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 1.1K 
[   ]dbr-Abagovomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 45  
[   ]dbr-Abagovomab-sub-10.ttl.bz22021-05-12 01:28 496  
[   ]dbr-Afelimomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 473  
[   ]dbr-Afelimomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 45  
[   ]dbr-Afelimomab-sub-10.ttl.bz22021-05-12 01:28 530  
[   ]dbr-Bectumomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 461  
[   ]dbr-Bectumomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 252  
[   ]dbr-Bectumomab-sub-10.ttl.bz22021-05-12 01:28 446  
[   ]dbr-Besilesomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 1.2K 
[   ]dbr-Besilesomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 184  
[   ]dbr-Besilesomab-sub-10.ttl.bz22021-05-12 01:28 507  
[   ]dbr-Blinatumomab-obj-10.ttl.bz22021-05-12 01:28 197  
[   ]dbr-Blinatumomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 1.5K 
[   ]dbr-Blinatumomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 278  
[   ]dbr-Blinatumomab-sub-10.ttl.bz22021-05-12 01:28 1.0K 
[   ]dbr-Catumaxomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 664  
[   ]dbr-Catumaxomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 486  
[   ]dbr-Catumaxomab-sub-10.ttl.bz22021-05-12 01:28 645  
[   ]dbr-Detumomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 246  
[   ]dbr-Detumomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 45  
[   ]dbr-Detumomab-sub-10.ttl.bz22021-05-12 01:28 379  
[   ]dbr-Edobacomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 407  
[   ]dbr-Edobacomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 45  
[   ]dbr-Edobacomab-sub-10.ttl.bz22021-05-12 01:28 612  
[   ]dbr-Edrecolomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 1.0K 
[   ]dbr-Edrecolomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 216  
[   ]dbr-Edrecolomab-sub-10.ttl.bz22021-05-12 01:28 524  
[   ]dbr-Elsilimomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 1.0K 
[   ]dbr-Elsilimomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 282  
[   ]dbr-Elsilimomab-sub-10.ttl.bz22021-05-12 01:28 466  
[   ]dbr-Ertumaxomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 1.0K 
[   ]dbr-Ertumaxomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 184  
[   ]dbr-Ertumaxomab-sub-10.ttl.bz22021-05-12 01:28 557  
[   ]dbr-Faralimomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 195  
[   ]dbr-Faralimomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 45  
[   ]dbr-Faralimomab-sub-10.ttl.bz22021-05-12 01:28 439  
[   ]dbr-Gavilimomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 890  
[   ]dbr-Gavilimomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 314  
[   ]dbr-Gavilimomab-sub-10.ttl.bz22021-05-12 01:28 443  
[   ]dbr-Indium_%28111In%29_biciromab-patterns-100-10000-4.yml.bz22021-05-12 01:28 774  
[   ]dbr-Indium_%28111In%29_biciromab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 228  
[   ]dbr-Indium_%28111In%29_biciromab-sub-10.ttl.bz22021-05-12 01:28 579  
[   ]dbr-Indium_%28111In%29_igovomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 689  
[   ]dbr-Indium_%28111In%29_igovomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 45  
[   ]dbr-Indium_%28111In%29_igovomab-sub-10.ttl.bz22021-05-12 01:28 475  
[   ]dbr-Indium_%28111In%29_imciromab-patterns-100-10000-4.yml.bz22021-05-12 01:28 447  
[   ]dbr-Indium_%28111In%29_imciromab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 301  
[   ]dbr-Indium_%28111In%29_imciromab-sub-10.ttl.bz22021-05-12 01:28 592  
[   ]dbr-Inolimomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 435  
[   ]dbr-Inolimomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 45  
[   ]dbr-Inolimomab-sub-10.ttl.bz22021-05-12 01:28 443  
[   ]dbr-Lemalesomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 257  
[   ]dbr-Lemalesomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 45  
[   ]dbr-Lemalesomab-sub-10.ttl.bz22021-05-12 01:28 434  
[   ]dbr-Lilotomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 549  
[   ]dbr-Lilotomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 178  
[   ]dbr-Lilotomab-sub-10.ttl.bz22021-05-12 01:28 458  
[   ]dbr-Maslimomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 223  
[   ]dbr-Maslimomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 45  
[   ]dbr-Maslimomab-sub-10.ttl.bz22021-05-12 01:28 386  
[   ]dbr-Minretumomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 645  
[   ]dbr-Minretumomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 45  
[   ]dbr-Minretumomab-sub-10.ttl.bz22021-05-12 01:28 545  
[   ]dbr-Mitumomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 1.0K 
[   ]dbr-Mitumomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 45  
[   ]dbr-Mitumomab-sub-10.ttl.bz22021-05-12 01:28 439  
[   ]dbr-Nerelimomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 221  
[   ]dbr-Nerelimomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 45  
[   ]dbr-Nerelimomab-sub-10.ttl.bz22021-05-12 01:28 519  
[   ]dbr-Odulimomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 670  
[   ]dbr-Odulimomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 45  
[   ]dbr-Odulimomab-sub-10.ttl.bz22021-05-12 01:28 420  
[   ]dbr-Oregovomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 574  
[   ]dbr-Oregovomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 252  
[   ]dbr-Oregovomab-sub-10.ttl.bz22021-05-12 01:28 540  
[   ]dbr-Pankomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 713  
[   ]dbr-Pankomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 45  
[   ]dbr-Pankomab-sub-10.ttl.bz22021-05-12 01:28 340  
[   ]dbr-Pemtumomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 950  
[   ]dbr-Pemtumomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 184  
[   ]dbr-Pemtumomab-sub-10.ttl.bz22021-05-12 01:28 473  
[   ]dbr-Racotumomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 1.3K 
[   ]dbr-Racotumomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 184  
[   ]dbr-Racotumomab-sub-10.ttl.bz22021-05-12 01:28 530  
[   ]dbr-Solitomab-obj-10.ttl.bz22021-05-12 01:28 198  
[   ]dbr-Solitomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 1.0K 
[   ]dbr-Solitomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 45  
[   ]dbr-Solitomab-sub-10.ttl.bz22021-05-12 01:28 434  
[   ]dbr-Technetium_%2899mTc%29_arcitumomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 584  
[   ]dbr-Technetium_%2899mTc%29_arcitumomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 150  
[   ]dbr-Technetium_%2899mTc%29_arcitumomab-sub-10.ttl.bz22021-05-12 01:28 835  
[   ]dbr-Technetium_%2899mTc%29_fanolesomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 556  
[   ]dbr-Technetium_%2899mTc%29_fanolesomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 184  
[   ]dbr-Technetium_%2899mTc%29_fanolesomab-sub-10.ttl.bz22021-05-12 01:28 716  
[   ]dbr-Technetium_%2899mTc%29_pintumomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 385  
[   ]dbr-Technetium_%2899mTc%29_pintumomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 45  
[   ]dbr-Technetium_%2899mTc%29_pintumomab-sub-10.ttl.bz22021-05-12 01:28 477  
[   ]dbr-Technetium_%2899mTc%29_sulesomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 1.3K 
[   ]dbr-Technetium_%2899mTc%29_sulesomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 45  
[   ]dbr-Technetium_%2899mTc%29_sulesomab-sub-10.ttl.bz22021-05-12 01:28 538  
[   ]dbr-Tenatumomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 230  
[   ]dbr-Tenatumomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 45  
[   ]dbr-Tenatumomab-sub-10.ttl.bz22021-05-12 01:28 453  
[   ]dbr-Tositumomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 1.3K 
[   ]dbr-Tositumomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 197  
[   ]dbr-Tositumomab-sub-10.ttl.bz22021-05-12 01:28 667  
[   ]dbr-Vepalimomab-patterns-100-10000-4.yml.bz22021-05-12 01:28 478  
[   ]dbr-Vepalimomab-propertypatterns-100-10000-4-10-4-5-50.yml.bz22021-05-12 01:28 45  
[   ]dbr-Vepalimomab-sub-10.ttl.bz22021-05-12 01:28 453  

Apache/2.4.52 (Ubuntu) Server at webtentacle1.techfak.uni-bielefeld.de Port 80